(firstQuint)Preventive Treatment of Episodic and Chronic Migraine.

 Patients with episodic migraine with and/or without aura and chronic migraine will be treated with 100 or 200 mg of milnacipran for a total of 4 months including a one month titration phase and a 3 month maintenance phase.

 Baseline (pre-treatment) and end-of-maintenance phase headache frequencies will be recorded.

 There is no placebo treatment in this study.

 In addition to headache frequencies, other parameters being measured include safety and tolerability.

.

 Preventive Treatment of Episodic and Chronic Migraine@highlight

This is an open label pilot study to determine whether milnacipran can reduce headache frequency in episodic and chronic migraine sufferers.

